Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained Joel South Tue, March 10, 2026 at 10:38 PM GMT+8 7 min read In this article: AMGN +0.59% O...